5Graham AN, Neale TJ, Hatfield PJ, et al. Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis. N Z Med J, 1986,99(805): 491-493.
6Prischl FC, Dieplinger G, Wallner M, et al. Peritoneal dialysis in patients with polyeystic kidney disease. Wien Klin Wochensehr, 2005, 117 Suppl 6: 24-28.
7Abbott KC, Agodoa LY. Polycystic kidney disease at endstage renal disease in the United States: patient characteristics and survival. Clin Nephrol, 2002, 57: 208- 214.
8Pirson Y, Christophe JL, Goffin E. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant, 1996, 11 Suppl 6: 24-28.
9Abbott KC, Agodoa LY. Etiology of bacterial septicemia in chronic dialysis patients in the United States. Clin Nephrol, 2001, 56: 124-131.
10Hadimeri H, Johansson AC, Haraldsson B, et al. CAPD in patients with autosomal dominant polycystic kidney disease. Perit Dial Int, 1998, 18: 429-432.
